John A. Lipani

Phase I/II trial of recombinant human granulocyte-macrophage colony- stimulating factor following allogeneic bone marrow transplantation

John Nemunaitis, CD Buckner, FR Appelbaum et al. · Blood · 1991 · 88 citations · Full text

Life Sciences, Hematology, Immunology +16

Comparative effects of nabumetone, sulindac, and ibuprofen on renal function.

M E Cook, John D. Wallin, Vashu Thakur et al. · PubMed · 1997 · 42 citations

Medicine, Pharmacology, Pharmacotherapy +9

Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.

Thasia Woodworth, D.E. Furst, Vibeke Strand et al. · PubMed · 2001 · 34 citations

Pharmacy, Clinical Sciences, Toxicology +16

Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.

Yocum De, Solinger Am, John Tesser et al. · PubMed · 1998 · 30 citations

Life Sciences, Clinical Sciences, Immunology +17

Clinical update of the relative safety of nabumetone in long-term clinical trials

John A. Lipani, Marcia Poland · Inflammopharmacology · 1995 · 25 citations

Pharmacy, Pharmacokinetics, Pharmacology +10